Sex as a profound modifier of atherosclerotic lesion development in apolipoprotein E-deficient mice with different genetic backgrounds

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 7, 2010, Pages 712-721

  Surra, Joaquín C ^a,b   Guillén, Natalia ^a,b   Arbonés Mainar, José M ^a   Barranquero, Cristina ^a,b   Navarro, María A ^a,b   Arnal, Carmen ^a,b   Orman, Israel ^c   Segovia, José C ^c   Osada, Jesús ^a,b  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Apolipoprotein; Atherosclerosis; Chitotriosidase; Mouse strains; Paraoxonase; Sex

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CHITOTRIOSIDASE; CLUSTERIN; FATTY ACID; GLUCONOLACTONASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

129 MOUSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; C57BL 6 MOUSE; CONTROLLED STUDY; DIET THERAPY; DISEASE COURSE; FAST PROTEIN LIQUID CHROMATOGRAPHY; FATTY ACID BLOOD LEVEL; FATTY LIVER; FEMALE; INFLAMMATION; LIPID METABOLISM; LIPID PEROXIDATION; LIVER HISTOLOGY; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN ISOLATION; SEX DIFFERENCE;

EID: 77955791931     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.3541     Document Type: Article

References (29)

1. Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P:Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis, 1985; 57: 65-73
2. Nishina PM, Wang J, Toyofuku W, Kuypers FA, Ishida BY, Paigen B: Atherosclerosis and plasma and liver lipids in nine inbred strains of mice. Lipids, 1993; 28: 599-605
3. Allayee H, Ghazalpour A, Lusis AJ: Using mice to dissect genetic factors in atherosclerosis. Arterioscler Thromb Vasc Biol, 2003; 23: 1501-1519
4. Sarria AJ, Surra JC, Acín S, Carnicer R, Navarro MA, Arbonés-Mainar JM, et al: Understanding the role of dietary components on atherosclerosis using genetic engineered mouse models. Front Biosci, 2006; 11: 955-967
5. Shi W, Wang NJ, Shih DM, Sun VZ, Wang X, Lusis AJ: Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ Res, 2000; 86: 1078-1084
6. Wang SS, Shi W, Wang X, Velky L, Greenlee S, Wang MT, et al: Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice. Arterioscler Thromb Vasc Biol, 2007; 27: 2671-2676
7. Wang X, Le Roy I, Nicodeme E, Li R, Wagner R, Petros C, et al: Using advanced intercross lines for high-resolutionmapping of HDL cholesterol quantitative trait loci. Genome Res, 2003; 13: 1654-1664
8. Guillén N, Acín S, Navarro MA, Perona JS, Arbonés-Mainar JM, Arnal C, et al: Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice. Atherosclerosis, 2008; 196: 558-564
9. Paigen B, Ishida BY, Verstuyft J, Winters RB, Albee D: Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis, 1990; 10: 316-323
10. Svenson KL, Von Smith R, Magnani PA, Suetin HR, Paigen B, Naggert JK, et al: Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations. J Appl Physiol,2007; 102: 2369-2378
11. Carnicer R, Guzmán MA, Acín S, Surra JC, Navarro MA, Arbonés-Mainar JM, et al: Genetic background in apolipoprotein A-I and cystathionine β-synthase deficiency. Frontiers in Bioscience, 2008; 13: 5155-5162
12. Canto JG, Goldberg RJ, Hand MM, Bonow RO, Sopko G, Pepine CJ, et al: Symptom presentation of women with acute coronary syndromes: myth vs reality. Arch Intern Med, 2007; 167: 2405-2413
13. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, et al: Insights from the HLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardio, 2006; 47: S4-S20
14. Sheps DS, Kaufmann PG, Sheffield D, Light KC, McMahon RP, Bonsall R, et al: Sex differences in chest pain in patients with documented coronary artery disease and exercise-induced ischemia: Results from the PIMI study. Am Heart J, 2001; 142: 864-871
15. Korstanje R, Li R, Howard T, Kelmenson P, Marshall J, Paigen B, et al: Influence of sex and diet on quantitative trait loci for HDL cholesterol levels in an SM/J by NZB/BlNJ intercross population. J Lipid Res, 2004; 45: 881-888
16. Acín S, Navarro MA, Carnicer R, Arbonés JM, Guzmán MA, Arnal C, et al: Dietary cholesterol suppresses the ability of olive oil to delay the development of atherosclerotic lesions in apolipoprotein E knockout mice. Atherosclerosis, 2005; 182: 17-28
17. Escolà-Gil JC, Jorba O, Julve-Gil J, González-Sastre F, Ordóñez-Llanos J, Blanco-Vaca F: Pitfalls of direct HDL cholesterol measurements in mouse models of hyperlipidemia and atherosclerosis. Clin Chem, 1999; 45: 1567-1569
18. Billecke S, Draganov D, Counsell R, Stetson P, Watson C, Hsu C, et al: Human serum paraoxonase (pon1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos, 2000; 28: 1335-1342
19. Arbonés-Mainar JM, Navarro MA, Guzmán MA, Arnal C, Surra JC, Acín S, et al: Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis, 2006; 189: 318-327
20. Navarro MA, Carpintero R, Acín S, Arbonés-Mainar JM, Calleja L, Carnicer R, et al: Immune-regulation of the apolipoprotein A-I/C-III /A-IV gene cluster in experimental inflammation. Cytokine, 2005; 31: 52-63
21. Calleja L, París MA, Paul A, Vilella E, Joven J, Jiménez A, et al: Low-cholesterol and high-fat diets reduce atherosclerotic lesion development in ApoE-knockout mice. Arterioscler Thromb Vasc Biol, 1999; 19: 2368-2375
22. Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, Fogelman AM: A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res, 2001; 42: 1308-1317
23. Paigen B, Morrow A, Holmes P, Mitchell D, Williams R: Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis, 1987; 68: 231-240
24. Libby P, Aikawa M: Stabilization of atherosclerotic plaques: New mechanisms and clinical targets. Nature Med, 2002; 8: 1257-1262
25. Veniant MM, Withycombe S, Young SG: Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-)mice. Arterioscler Thromb Vasc Biol, 2001; 21: 1567-1570
26. Castellani LW, Nguyen CN, Charugundla S, Weinstein MM, Doan CX, Blaner WS, et al: Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance. J Biol Chem, 2008; 283: 11633-11644
27. Tailleux A, Duriez P, Fruchart JC, Clavey V: Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis, 2002; 164: 1-13
28. Guan HP, Goldstein JL, Brown MS, Liang G: Accelerated fatty acid oxidation in muscle averts fasting-induced hepatic steatosis in SJL/J mice. J Biol Chem, 2009; 284: 24644-24652
29. Stillemark-Billton P, Beck C, Boren J, Olofsson SO: Relation of the size and intracellular sorting of apoB to the formation of VLDL 1 and VLDL 2. J Lipid Res, 2005; 46: 104-114